Arcus Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 11/13/2025 | 31.42 M | $427.38 M | 0.00% | 29.62% |
| BLACKROCK, INC. | 11/12/2025 | 11.81 M | $160.63 M | 3.08% | 11.13% |
| VANGUARD GROUP INC | 11/07/2025 | 6.63 M | $90.16 M | 1.12% | 6.25% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 4.33 M | $58.92 M | -27.39% | 4.08% |
| WOODLINE PARTNERS LP | 11/14/2025 | 3.77 M | $51.27 M | -5.76% | 3.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 3.69 M | $50.17 M | 0.00% | 3.48% |
| STATE STREET CORP | 11/14/2025 | 3.39 M | $46.17 M | -6.50% | 3.20% |
| SIREN, L.L.C. | 11/13/2025 | 2.91 M | $39.60 M | 80.64% | 2.74% |
| FMR LLC | 11/13/2025 | 2.30 M | $31.23 M | -10.78% | 2.16% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 1.77 M | $24.11 M | 3.81% | 1.67% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.60 M | $21.74 M | 0.13% | 1.51% |
| MORGAN STANLEY | 11/14/2025 | 1.54 M | $20.89 M | 4.51% | 1.45% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.50 M | $20.43 M | -9.48% | 1.42% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/07/2025 | 1.42 M | $19.31 M | 1.74% | 1.34% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.36 M | $18.51 M | 173.46% | 1.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 1.27 M | $17.22 M | 35.28% | 1.19% |
| BARCLAYS PLC | 11/12/2025 | 1.27 M | $17.22 M | 0.00% | 1.19% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 1.22 M | $16.62 M | 0.51% | 1.15% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 1.14 M | $15.45 M | 0.00% | 1.07% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 1.12 M | $15.23 M | 39.09% | 1.06% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 950.59 K | $12.93 M | 46.68% | 0.90% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 871.15 K | $11.85 M | 12.15% | 0.82% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2025 | 729.15 K | $9.92 M | 727.05% | 0.69% |
| NORTHERN TRUST CORP | 11/14/2025 | 707.80 K | $9.63 M | 2.39% | 0.67% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 652.68 K | $8.88 M | 8.85% | 0.62% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 634.94 K | $8.64 M | -18.61% | 0.60% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 627.63 K | $8.54 M | 0.00% | 0.59% |
| DECHENG CAPITAL LLC | 11/14/2025 | 547.61 K | $7.45 M | 242.26% | 0.52% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 471.52 K | $6.41 M | 15.51% | 0.44% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 470.21 K | $6.39 M | -2.86% | 0.44% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 455.60 K | $6.20 M | -7.14% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 389.14 K | $5.29 M | 11.67% | 0.37% |
| PDT PARTNERS, LLC | 11/17/2025 | 388.34 K | $5.28 M | -0.24% | 0.37% |
| MACQUARIE GROUP LTD | 11/13/2025 | 379.10 K | $5.16 M | 0.00% | 0.36% |
| CANDRIAM S.C.A. | 11/06/2025 | 378.44 K | $5.15 M | 100.00% | 0.36% |
| SECTORAL ASSET MANAGEMENT INC | 11/14/2025 | 368.07 K | $5.01 M | 43.07% | 0.35% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2025 | 340.00 K | $4.62 M | -20.93% | 0.32% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 334.52 K | $4.55 M | -0.51% | 0.32% |
| ABRDN PLC | 11/07/2025 | 331.67 K | $4.42 M | 100.00% | 0.31% |
| NORDEA INVESTMENT MANAGEMENT AB | 10/27/2025 | 328.46 K | $4.33 M | 2.68% | 0.31% |
| CITADEL ADVISORS LLC | 11/14/2025 | 295.05 K | $4.01 M | -51.73% | 0.28% |
| INVESCO LTD. | 11/13/2025 | 292.40 K | $3.98 M | 16.10% | 0.28% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 285.40 K | $3.88 M | -3.52% | 0.27% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/06/2025 | 269.86 K | $3.67 M | 16.81% | 0.25% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 250.00 K | $3.40 M | 100.00% | 0.24% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 239.97 K | $3.26 M | -3.23% | 0.23% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 239.42 K | $3.26 M | 100.00% | 0.23% |
| AXA INVESTMENT MANAGERS S.A. | 11/14/2025 | 232.67 K | $3.16 M | 100.00% | 0.22% |
| JANE STREET GROUP, LLC | 11/14/2025 | 225.63 K | $3.07 M | -53.20% | 0.21% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 219.30 K | $2.98 M | -40.42% | 0.21% |
Arcus Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 245 institutional investors and hedge funds held shares of Arcus Biosciences, Inc.. The most heavily invested institutionals were:
GILEAD SCIENCES, INC.: 31.42 M
BlackRock, Inc.: 11.81 M
VANGUARD GROUP INC: 6.63 M
Point72 Asset Management, L.P.: 4.33 M
Woodline Partners LP: 3.77 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 3.69 M
94.83% of Arcus Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 116.82 M shares in the last 24 months. This purchase volume represents approximately $1.56 B in transactions.